Floatz logo

Phosphatidylcholine

Metabolism, Inborn Errors

National Center for Research Resources (NCRR)N/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Metabolism, Inborn Errors cohort.

Asset / SponsorPhaseRating
Nexiguran Ziclumeran
Intellia Therapeutics
Phase 3B
Mgta-456
Magenta Therapeutics, Inc.
Phase 2B
Hpc, Cord Blood
Memorial Sloan Kettering Cancer Center
Phase 2CCC
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Paul Szabolcs
Phase 2CCC
Clofarabine
Memorial Sloan Kettering Cancer Center
Phase 2CCC

View all 17 →

Same molecule, other indications

Phosphatidylcholine is also rated in:

schizophreniaDormant
CC
Indicative ·
41 / 100
View asset →
methionine adenosyltransferase deficiencyDormant
NR
Indicative ·
/ 100
View asset →
Diminished P50 Sensory GatingDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →